INFORMATION ON THE CORONAVIRUS
The Leukemia & Lymphoma Society is monitoring closely coronavirus (COVID-19) developments. As a health organization, one of our highest priorities is the well-being of our employees, volunteers, donors, partners, and the patients we serve – especially as many blood cancer patients are immunocompromised.
We are following vigilantly U.S. Centers for Disease Control and Prevention (CDC) guidelines to evaluate our plans and act in a timely and responsible way.
To learn more, we recommend reading these posts on the LLS Blog by our Chief Medical Officer Dr. Gwen Nichols:
4 Things Cancer Patients Need To Know About The Coronavirus
Helping Blood Cancer Patients Adjust to the New Normal
FAQ:
Q. What is LLS’s advice for patients and caregivers who have questions about coronavirus?
A. LLS Information Specialists – master’s level oncology professionals who provide free, personalized assistance to patients, families and healthcare providers – are available to speak one-on-one with patients and caregivers. Patients and caregivers can call (800) 955-4572 from Monday to Friday, 9 a.m. to 9 p.m. ET or visit www.lls.org/support/information-specialists.
Q. How is LLS handling upcoming in-person fundraising events and patient education programs such as Blood Cancer Conferences?
A. The Leukemia & Lymphoma Society (LLS) continues to monitor coronavirus (COVID-19) developments. As a health organization, one of our highest priorities is the well-being of our employees, volunteers, donors, partners and the patients we serve – especially as many blood cancer patients are immunocompromised.
Given the escalating cases of coronavirus COVID-19 and concern among our staff and communities across the country, LLS is postponing our in-person fundraising events scheduled through April 30, and postponing in-person events for patients, caregivers and healthcare professionals through May 15. Our staff will be working from home until March 31. When possible, we will provide virtual opportunities to continue to drive forward our important mission work.
We are following vigilantly guidance from the U.S. Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and local public health officials as we continue to evaluate our plans and act in a timely and responsible way.